Posted by Michael Wonder on 15 Dec 2015

FDA approves Bridion to reverse effects of neuromuscular blocking drugs used during surgery

FDA

15 December 2015 - The U.S. FDA today approved Bridion (sugammadex sodium) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm477512.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US